Genflow Biosciences Plc (GB:GENF)
LSE:GENF
Want to see GB:GENF full AI Analyst Report?
Total Valuation
Genflow Biosciences Plc has a market cap or net worth of £14.25M. The enterprise value is 13.97M .
Market Cap£14.25M
Enterprise Value13.97M
Share Statistics
Genflow Biosciences Plc has 535,653,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding535,653,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genflow Biosciences Plc’s return on equity (ROE) is 2.57 and return on invested capital (ROIC) is 363.69%.
Return on Equity (ROE)2.57
Return on Assets (ROA)-3.13
Return on Invested Capital (ROIC)363.69%
Return on Capital Employed (ROCE)3.64
Revenue Per Employee0.00
Profits Per Employee-283.51K
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Genflow Biosciences Plc is ―. Genflow Biosciences Plc’s PEG ratio is 0.19.
PE Ratio―
PS Ratio0.00
PB Ratio-14.33
Price to Fair Value-14.33
Price to FCF-5.50
Price to Operating Cash Flow-8.00
PEG Ratio0.19
Income Statement
In the last 12 months, Genflow Biosciences Plc had revenue of 0.00 and earned -1.42M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-1.09K
Operating Income-2.00M
Pretax Income-1.42M
Net Income-1.42M
EBITDA-2.00M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.28M and capital expenditures 372.00, giving a free cash flow of -1.28M billion.
Operating Cash Flow-1.28M
Free Cash Flow-1.28M
Free Cash Flow per Share>-0.01
Dividends & Yields
Genflow Biosciences Plc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.31
52-Week Price Change212.94%
50-Day Moving Average1.94
200-Day Moving Average1.58
Relative Strength Index (RSI)63.51
Average Volume (3m)1.73M
Important Dates
Genflow Biosciences Plc upcoming earnings date is Sep 25, 2026, Before Open (Not Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateSep 25, 2026
Ex-Dividend Date―
Financial Position
Genflow Biosciences Plc as a current ratio of 0.45, with Debt / Equity ratio of 0.00%
Current Ratio0.45
Quick Ratio0.45
Debt to Market Cap0.00
Net Debt to EBITDA0.06
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Genflow Biosciences Plc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Genflow Biosciences Plc EV to EBITDA ratio is -3.89, with an EV/FCF ratio of -5.42.
EV to Sales0.00
EV to EBITDA-3.89
EV to Free Cash Flow-5.42
EV to Operating Cash Flow-5.42
Balance Sheet
Genflow Biosciences Plc has £279.44K in cash and marketable securities with £0.00 in debt, giving a net cash position of £279.44K billion.
Cash & Marketable Securities£279.44K
Total Debt£0.00
Net Cash£279.44K
Net Cash Per Share<£0.01
Tangible Book Value Per Share>-£0.01
Margins
Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin100.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Genflow Biosciences Plc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast29.79%